121 related articles for article (PubMed ID: 19278051)
1. Inverse association of leptin levels with renal cell carcinoma: results from a case-control study.
Spyridopoulos TN; Petridou ET; Dessypris N; Terzidis A; Skalkidou A; Deliveliotis C; Chrousos GP;
Hormones (Athens); 2009; 8(1):39-46. PubMed ID: 19278051
[TBL] [Abstract][Full Text] [Related]
2. Insulin resistance and risk of renal cell cancer: a case-control study.
Spyridopoulos TN; Dessypris N; Antoniadis AG; Gialamas S; Antonopoulos CN; Katsifoti K; Adami HO; Chrousos GP; Petridou ET;
Hormones (Athens); 2012; 11(3):308-15. PubMed ID: 22908063
[TBL] [Abstract][Full Text] [Related]
3. Low adiponectin levels are associated with renal cell carcinoma: a case-control study.
Spyridopoulos TN; Petridou ET; Skalkidou A; Dessypris N; Chrousos GP; Mantzoros CS;
Int J Cancer; 2007 Apr; 120(7):1573-8. PubMed ID: 17205522
[TBL] [Abstract][Full Text] [Related]
4. Serum leptin and adiponectin levels and risk of renal cell carcinoma.
Liao LM; Schwartz K; Pollak M; Graubard BI; Li Z; Ruterbusch J; Rothman N; Davis F; Wacholder S; Colt J; Chow WH; Purdue MP
Obesity (Silver Spring); 2013 Jul; 21(7):1478-85. PubMed ID: 23666639
[TBL] [Abstract][Full Text] [Related]
5. Prediagnostic circulating adipokine concentrations and risk of renal cell carcinoma in male smokers.
Liao LM; Weinstein SJ; Pollak M; Li Z; Virtamo J; Albanes D; Chow WH; Purdue MP
Carcinogenesis; 2013 Jan; 34(1):109-12. PubMed ID: 23042303
[TBL] [Abstract][Full Text] [Related]
6. Circulating levels of obesity-related markers and risk of renal cell carcinoma in the PLCO cancer screening trial.
Liao LM; Hofmann JN; Cho E; Pollak MN; Chow WH; Purdue MP
Cancer Causes Control; 2017 Jul; 28(7):801-807. PubMed ID: 28484923
[TBL] [Abstract][Full Text] [Related]
7. Role of leptin as a biomarker for early detection of renal cell carcinoma? No evidence from a systematic review and meta-analysis.
Perumal K; Huin WK; Yap NY; Ong TA; Gobe GC; Rajandram R
Med Hypotheses; 2019 Aug; 129():109239. PubMed ID: 31371068
[TBL] [Abstract][Full Text] [Related]
8. Circulating levels of adipocytokine omentin-1 in patients with renal cell cancer.
Shen XD; Zhang L; Che H; Zhang YY; Yang C; Zhou J; Liang CZ
Cytokine; 2016 Jan; 77():50-5. PubMed ID: 26539805
[TBL] [Abstract][Full Text] [Related]
9. A higher circulating concentration of 25-hydroxyvitamin-D decreases the risk of renal cell carcinoma: a case-control study.
Li F; Zhao H; Hou L; Ling F; Zhang Y; Tan W
Int Braz J Urol; 2019; 45(3):523-530. PubMed ID: 30785699
[TBL] [Abstract][Full Text] [Related]
10. The role of obesity and weight fluctuations in the etiology of renal cell cancer: a population-based case-control study.
Lindblad P; Wolk A; Bergström R; Persson I; Adami HO
Cancer Epidemiol Biomarkers Prev; 1994 Dec; 3(8):631-9. PubMed ID: 7881335
[TBL] [Abstract][Full Text] [Related]
11. History of treated hypertension and diabetes mellitus and risk of renal cell cancer.
Zucchetto A; Dal Maso L; Tavani A; Montella M; Ramazzotti V; Talamini R; Canzonieri V; Garbeglio A; Negri E; Franceschi S; La Vecchia C
Ann Oncol; 2007 Mar; 18(3):596-600. PubMed ID: 17158772
[TBL] [Abstract][Full Text] [Related]
12. Identifying the emerging role of adipokine as a diagnostic and prognostic biomarker of renal cell carcinoma.
Choi SH; Chun SY; Kim TH; Kwon TG
Urol Oncol; 2016 Jun; 34(6):259.e15-9. PubMed ID: 26992934
[TBL] [Abstract][Full Text] [Related]
13. Diet and vitamin or mineral supplements and risk of renal cell carcinoma in Canada.
Hu J; Mao Y; White K;
Cancer Causes Control; 2003 Oct; 14(8):705-14. PubMed ID: 14674734
[TBL] [Abstract][Full Text] [Related]
14. Association between leptin level and renal cell carcinoma susceptibility and progression: A meta-analysis.
Zhu H; Li W; Mao S; Wang L
J Cancer Res Ther; 2018; 14(4):873-880. PubMed ID: 29970669
[TBL] [Abstract][Full Text] [Related]
15. History of urinary tract infection and risk of renal cell carcinoma.
Parker AS; Cerhan JR; Lynch CF; Leibovich BC; Cantor KP
Am J Epidemiol; 2004 Jan; 159(1):42-8. PubMed ID: 14693658
[TBL] [Abstract][Full Text] [Related]
16. The impact of obesity and adiponectin signaling in patients with renal cell carcinoma: A potential mechanism for the "obesity paradox".
Ito R; Narita S; Huang M; Nara T; Numakura K; Takayama K; Tsuruta H; Maeno A; Saito M; Inoue T; Tsuchiya N; Satoh S; Habuchi T
PLoS One; 2017; 12(2):e0171615. PubMed ID: 28178338
[TBL] [Abstract][Full Text] [Related]
17. Higher fetuin-A, lower adiponectin and free leptin levels mediate effects of excess body weight on insulin resistance and risk for myelodysplastic syndrome.
Dalamaga M; Karmaniolas K; Chamberland J; Nikolaidou A; Lekka A; Dionyssiou-Asteriou A; Mantzoros CS
Metabolism; 2013 Dec; 62(12):1830-9. PubMed ID: 24140093
[TBL] [Abstract][Full Text] [Related]
18. Low circulating adiponectin and resistin, but not leptin, levels are associated with multiple myeloma risk: a case-control study.
Dalamaga M; Karmaniolas K; Panagiotou A; Hsi A; Chamberland J; Dimas C; Lekka A; Mantzoros CS
Cancer Causes Control; 2009 Mar; 20(2):193-9. PubMed ID: 18814045
[TBL] [Abstract][Full Text] [Related]
19. Serum leptin-adiponectin ratio and endometrial cancer risk in postmenopausal female subjects.
Ashizawa N; Yahata T; Quan J; Adachi S; Yoshihara K; Tanaka K
Gynecol Oncol; 2010 Oct; 119(1):65-9. PubMed ID: 20674961
[TBL] [Abstract][Full Text] [Related]
20. Adipocytokines and breast cancer risk.
Hou WK; Xu YX; Yu T; Zhang L; Zhang WW; Fu CL; Sun Y; Wu Q; Chen L
Chin Med J (Engl); 2007 Sep; 120(18):1592-6. PubMed ID: 17908478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
